Bizarre Patents
Decorative Jeweled Wheel Cover
An improved wheel is provided wherein decorative items such as gem stones are embedded in either the wheel surface, a special mounting section attached to the wheel surface, or to a spoke strap that wraps around each spoke and positions embedded gem stones on the outside surface of the spoke.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 5538725 | Method of inhibiting metastasis by anti-댖-integrin-antibodies Polypeptides which bind to mammalian 댖-integrin and inhibit metastasis.... | 07/23/1996 |
| 5508430 | Oxirane intermediates for novel alcohols Novel alcohols of the formula ##STR1## wherein Ra is azido or phthalimido, R4 is alkyl, cycloalkyl, cycloalkylalkyl, aryl or aralkyl, R7 and R8 together are a trimethylene or tetramethylene group which is o... | 04/16/1996 |
| 5488115 | Alcohols Novel alcohols of the formula ##STR1## wherein Ra is azido or phthalimido, R4 is alkyl, cycloalkyl, cycloalkylalkyl, aryl or aralkyl, R7 and R8 together are a trimethylene or tetramethylene group which is o... | 01/30/1996 |
| 5451678 | Alcohols Novel alcohols of the formula ##STR1## wherein Ra is azido or phthalimido, R4 is alkyl, cycloalkyl, cycloalkylalkyl, aryl or aralkyl, R7 and R8 together are a trimethylene or tetramethylene group which is o... | 09/19/1995 |
| 5449785 | Cyclohexane derivatives Compounds of the formula ##STR1## which have antifungal activity.... | 09/12/1995 |
| 5418147 | Glycosyl-phosphatidylinositol-specific phospholipase D The present invention involves the protein glycosyl-phosphatidyl-specific phospholipase D (GPI-PLD) in a substantially pure form, an isolated nucleotide sequence encoding GPI-PLD, vectors containing the isolated nucleotide sequence encoding GPI-PLD, and c... | 05/23/1995 |
| 5405866 | Multidrug resistance modifying dithianes Compounds of the formula. ##STR1## wherein R is a residue of the formula ##STR2## and R1, R2, R3, R4, R5, R6, R7, X, Y and Z are as described, with the exception of ... | 04/11/1995 |
| 5403581 | Coccidiosis vaccines The invention provides an immunogenic polypeptide having the amino acid sequence ##STR1## which polypeptides are capable of inducing an immune response against Eimeria parasites, and the DNA encoding such polypeptides, as well as recombinant vec... | 04/04/1995 |
| 5395750 | Methods for producing proteins which bind to predetermined antigens Methods of producing a protein capable of binding to a predetermined antigen, screening libraries containing such proteins, and proteins and synthetic genes containing randomized sequences are disclosed.... | 03/07/1995 |
| 5382657 | Peg-interferon conjugates Substituted PEG-interferon conjugates of formulae IA and IB where PEG is linked by means of activated linking reagents of formulae IIA, IIB, or IIB-1 to an amino group in the interferon, and activated linking reagents of formulae IIA, IIB, or IIB-1. The c... | 01/17/1995 |
| 5372746 | Fluoro-substituted tolane compounds and liquid crystalline mixtures containing same Compounds of the general formula ##STR1## wherein ring A represents 1,4-phenylene, pyridine-2,5-diyl, pyrimidine-2,5-diyl, trans-1,4-cyclohexylene or trans-1,3-dioxane-2,5-diyl; Z signifies a single covalent bond, --CH2 CH2 --, ... | 12/13/1994 |
| 5302727 | Multidrug resistance modifying dithianes Compounds of the formula ##STR1## wherein R is a residue of the formula ##STR2## and R1, R2, R3, R4, R5, R6, R7, X, Y and Z are as described, with the exception of ... | 04/12/1994 |
| 5252604 | Compositions of retinoic acids and tocopherol for prevention of dermatitis Compositions of retinoic acids and tocopherols which may be applied topically without producing retinoic acid-induced skin irritation.... | 10/12/1993 |
| 5227507 | Ethynylcyclohexene compounds and processes for manufacture thereof A process for the manufacture of compounds of the general formula ##STR1## wherein R1 signifies hydroxy or an etherified hydroxy group, and of zeaxanthin by converting a compound of the general formula ##STR2## wherein R1 h... | 07/13/1993 |
| 5225534 | Recombinant malarial polypeptides The invention provides polypeptides which correspond in at least one specific epitope with a plasmodium falciparum merozoite antigen having a molecular weight of about 41,000 Daltons, and a process for their production. The invention further provides immu... | 07/06/1993 |
| 5221735 | Cyclodextrin-polyene inclusion complexes Inclusion complexes of the polyenes apocarotenal and lycopene in a cyclodextrin as well as their manufacture are described. The inclusion complexes are soluble in water, alcohol or water/alcohol mixtures.... | 06/22/1993 |
| 5214162 | Process for manufacturing 5-cyano-4-lower alkyloxazoles The invention is concerned with a process for the manufacture of 5-cyano-4-lower alkyl-oxazoles by dehydrating a 5-carbamoyl-4-lower alkyl-oxazole in the gas phase in the presence of a heterogeneous catalyst based on silicon dioxide and in the presence of... | 05/25/1993 |
| 5182205 | Nucleotide sequences which are selectively expressed in pre-B cells and probes therefor The present invention provides nucleotide sequences which are selectively expressed in pre-B cells, probes comprising a polynucleotide hybridizing specifically to such a nucleotide sequence and methods for the production of such probes. These probes may b... | 01/26/1993 |
| 5162577 | Process for lithiation of 1,3-bis(trifluoromethyl)benzene A novel process for the lithiation of 1,3-bis(trifluoro-methyl)benzene in a solvent is described, said process comprising carrying out the lithiation with the lithium salt of an amine of the general formula R1 R2 NH ... | 11/10/1992 |
| 5155255 | Process for producing cycloalkenylalkenes A process for the manufacture of certain cycloalkenylalkenes, e.g. vitamin A acetate, comprises dehydrating 1-(5-acetoxy-3-methyl-penta-1,3-dienyl)-2,6,6-trimethyl-cyclo hexanol or 4 aetoxy-1-(5-acetoxy-3-methyl-penta-1,3-dienyl)-2,6,6-trimethyl-cyclohexa... | 10/13/1992 |
| 5153344 | Vitamin E intermediates and a process for their manufacture and conversion into vitamin E Novel methyl carbinol derivatives of Vitamin E and a method for their manufacture.... | 10/06/1992 |
| 5147854 | TGF-B compositions and method Transforming growth factor-beta (TGF-beta) is enhanced in its therapeutic activity by utilizing it in combination with a synergistic effective amount of a polyunsaturated fatty acid (PUFA). In a preferred embodiment, type 1 transforming growth factor beta... | 09/15/1992 |
| 5134240 | Bicyclic peroxides Novel 4-substituted-4,8-dimethyl-2,3-dioxabicyclo[3.3.1] nonan-7-ones which have a pronounced activity against the causative organism of malaria and can be used for the prevention and control of malaria.... | 07/28/1992 |
| 5132464 | Hydrogenation process There is disclosed a catalytic hydrogenation process resulting in compounds of the formula ##STR1## wherein the dotted line represents a facultative bond, by hydrogenating the compound of the formula ##STR2## in the presence of a platinum o... | 07/21/1992 |
| 5114713 | P. falciparum CS-peptides as universal T-cell epitope The present invention relates to the use of a peptide from the circumsporozoite (CS) protein of Plasmodium falciparum (P. falciparum) and the derivatives thereof as a universally recognized T-cell epitope i.e. an epitope which is recognized in association... | 05/19/1992 |
